Video Experimental Relacionado

Updated: Jan 31, 2026

Non-chromatographic Purification of Recombinant Elastin-like Polypeptides and their Fusions with Peptides and Proteins from Escherichia coli

Non-chromatographic Purification of Recombinant Elastin-like Polypeptides and their Fusions with Peptides and Proteins from Escherichia coli

Published on: June 9, 2014

Proteínas de Fusión Genéticamente Codificadas de Polipéptidos Tipo Elastina-Haemadina Multivalentes para una

Hui Yang^1,2, Lianlian Liang¹, Shuo Su¹

¹School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 211816, China.

Biomacromolecules

|January 30, 2026

Resumen

Hemos diseñado una proteína de fusión que combina la haemadina (un inhibidor de la trombina) con polipéptidos tipo elastina (ELP) para la terapia antitrombótica sostenida. Esta plataforma proporciona liberación de fármacos a demanda, mejorando la seguridad y la conveniencia de los péptidos terapéuticos.

Área de la Ciencia:

Biotecnología
Farmacología
Bioquímica

Sus antecedentes:

Los terapéuticos peptídicos enfrentan limitaciones debido a sus cortas vidas medias en plasma, lo que requiere una dosificación frecuente.
Esto conduce a variabilidad farmacocinética y posibles efectos secundarios.
El desarrollo de estrategias para la administración de péptidos sostenida y controlada es crucial para el éxito clínico.

Objetivo del estudio:

Crear una plataforma de proteínas de fusión genéticamente codificable para la administración de péptidos de fármacos sostenida y sensible a estímulos.
Combinar un inhibidor de la trombina (haemadina) con un polipéptido tipo elastina (ELP) para mejorar la terapia antitrombótica.
Permitir la activación a demanda de la actividad terapéutica y mejorar la conveniencia de la dosificación.

Principales métodos:

Se desarrolló una proteína de fusión que une la haemadina y el ELP a través de enlazadores escindibles por el factor Xa (FXa).
Se utilizó la inyección subcutánea para la formación de depósitos in situ a través de la condensación de ELP inducida por temperatura.
Se logró una expresión de alto rendimiento y purificación no cromatográfica de la proteína de fusión.

Principales resultados:

La proteína de fusión formó un depósito in situ tras la inyección subcutánea, permitiendo la liberación lenta de un profármaco inactivado.
El FXa asociado al trombo escindió el enlazador, liberando haemadina activa específicamente en el sitio de la trombosis.
La administración subcutánea prolongó significativamente la protección antitrombótica después de la inyección.

Conclusiones:

La plataforma de proteínas de fusión desarrollada ofrece carga de fármacos ajustable, liberación a largo plazo y activación sensible a estímulos.
Este enfoque mejora la seguridad, eficacia y conveniencia de dosificación de los terapéuticos peptídicos.
La tecnología muestra un fuerte potencial para mejorar la aplicación clínica de fármacos basados en péptidos.

Palabras clave:

proteína de fusión polipéptido tipo elastina haemadina terapia antitrombótica liberación de fármacos ingeniería de proteínas

Más Videos Relacionados

Optical Control of a Neuronal Protein Using a Genetically Encoded Unnatural Amino Acid in Neurons

Optical Control of a Neuronal Protein Using a Genetically Encoded Unnatural Amino Acid in Neurons

Published on: March 28, 2016

Production of Elastin-like Protein Hydrogels for Encapsulation and Immunostaining of Cells in 3D

Production of Elastin-like Protein Hydrogels for Encapsulation and Immunostaining of Cells in 3D

Published on: May 19, 2018

Videos de Conceptos Relacionados

Tagging and Fusion Proteins

Tagging and Fusion Proteins

Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...

Proteins: From Genes to Degradation

Proteins: From Genes to Degradation

Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...

Nuclear Fusion

Nuclear Fusion

The process of converting very light nuclei into heavier nuclei is also accompanied by the conversion of mass into large amounts of energy, a process called fusion. The principal source of energy in the sun is a net fusion reaction in which four hydrogen nuclei fuse and ultimately produce one helium nucleus and two positrons.
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...

Animal Mitochondrial Genetics

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...

Encoding

Encoding

Information enters the brain through encoding, which is the input of information into the memory system. Once sensory information is received from the environment, the brain labels or codes it. The information is then organized with similar information and connected to existing concepts. Encoding occurs through automatic processing and effortful processing.
Automatic processing involves the encoding of details like time, space, frequency, and the meaning of words, usually done without conscious...

Elastin is Responsible for Tissue Elasticity

Elastin is Responsible for Tissue Elasticity

Elastic fiber contains the protein elastin along with lesser amounts of other proteins and glycoproteins. The main property of elastin is that it will return to its original shape after being stretched or compressed. Elastic fibers are prominent in elastic tissues found in skin and the elastic ligaments of the vertebral column.
Ligaments and tendons are made of dense regular connective tissue, but in ligaments not all fibers are parallel. Dense regular elastic tissue contains elastin fibers and...